Some GLP-1 medicines have shown cardiovascular benefits and are prioritized for many people with type 2 diabetes who have established heart disease or high cardiovascular risk, according to ADA Standards of Care
For instance, one study from the journal Frontiers in Medicine found that people with psoriasis had significantly lower levels of glutathione
Estimates for individual agents were consistent with the overall finding: dulaglutide (OR = 0.22, 95% CI 0.160.31), exenatide (OR = 0.26, 95% CI 0.180.37), liraglutide (OR = 0.23, 95% CI 0.180.29), and semaglutide (OR = 0.30, 95% CI 0.200.44)
Switching to semaglutide This is the most common switch
My suspicion would be that any benefit that somebody got from this would be much more likely due to a placebo effect than actual increased production of GLP-1, says Dr